Biography

Dr Hider came to Keele in 2007 as an NIHR Walport Clinical Lecturer in Rheumatology. Following her undergraduate medical training in Nottingham (1996) she undertook clinical postgraduate training in Manchester with an MSc Clinical Rheumatology (awarded with distinction, 2003) and a Ph.D. (2007) examining clinical and genetic predictors of response to methotrexate in rheumatoid arthritis. She was appointed as a consultant rheumatologist and clinical lecturer in 2009 (promoted to Senior Lecturer in 2012, and Reader in 2017) as is a Fellow of the Royal College of Physicians.

Dr Hider is the Director of Postgraduate Research for the Faculty of Medicine and Health Sciences and co-Lead for the INSPIRE research programme (supported by Academy of Medical Sciences, Wellcome Trust and North Staffordshire Medical Institute).

Research and scholarship

My research focuses on the optimal diagnosis and management of common inflammatory rheumatological conditions especially rheumatoid arthritis (RA), polymyalgia rheumatica and gout. I am interested in the long term impacts of chronic inflammatory conditions, especially the overlap between physical and mental health and management of multimorbidity.

I am passionate about engaging others with clinical research and am Director of Postgraduate Research for the Faculty of Medicine and Health Sciences. I enjoy supervising postgraduates students and have supervised 3 PhDs to completion (one ongoing) and 4 MPhil projects to completion. I am co-lead for the ASPIRE (formerly INSPIRE) medical research programme (established with support from North Staffordshire Medical Institute, Academy of Medical Sciences & Wellcome Trust) which aims to engage medical undergraduates with research.

Teaching

Dr Hider regularly teaches medical students in clinics, seminars and special study modules. She is also a medical student examiner and lectures on the Rheumatology Nursing MSc and ASPIRE course. She is an educational supervisor for Rheumatology Academic Foundation trainees and a personal development tutor for undergraduates.

Further information

  • Currently serves on the Royal College of Physicians Research and Academic Medicine Committee
  • British Society for Rheumatology Heberden Committee (2016-2019)
  • British Society for Rheumatology Peer Review (2015-2017)

Selected Publications

  • Twohig H, Owen C, Muller S, Mallen C, Mitchell C, Hider S, Hill C, Shea B, Mackie S. 2020. Outcomes Measured in Polymyalgia Rheumatica and Measurement Properties of Instruments Considered for the OMERACT Core Outcome Set: A Systematic Review. J Rheumatol. link> doi> full text>
  • Hendry GJ, Bearne L, Foster N, Godfrey E, Hider S, van der Leeden M, Mason H, McConnachie A, McInnes I, Patience A, Sackley C, Sekhon M, Williams A, Woodburn J, Steultjens M. 2020. A MIXED METHODS FEASIBILITY STUDY OF A GAIT REHABILITATION PROGRAMME FOR PEOPLE WITH EARLY RHEUMATOID ARTHRITIS AND FOOT PAIN. RHEUMATOLOGY (vol. 59, p. 64). link> doi>
  • Watson L, Belcher J, Nicholls E, Chandratre P, Blagojevic-Bucknall M, Hider S, Lawton SA, Mallen CD, Muller S, Rome K, Roddy E. 2020. FACTORS ASSOCIATED WITH CHANGE IN HEALTH-RELATED QUALITY OF LIFE IN PEOPLE LIVING WITH GOUT: A THREE-YEAR PROSPECTIVE COHORT STUDY IN PRIMARY CARE. RHEUMATOLOGY (vol. 59). link> doi>
  • Feddah H, Muller S, Hider S, Hay C, Mallen C. 2020. GASTROINTESTINAL SYMPTOMS AND PROTON PUMP INHIBITOR USE IN PATIENTS WITH POLYMYALGIA RHEUMATICA: RESULTS FROM THE PMR COHORT STUDY. RHEUMATOLOGY (vol. 59). link> doi>
  • Scott IC, Bajpai R, Hider SL, Helliwell T, Muller S, Mallen C. 2020. The relationship between obesity and outcomes in patients with polymyalgia rheumatica. Rheumatology. link> doi>

Full Publications List show

Journal Articles

  • Twohig H, Owen C, Muller S, Mallen C, Mitchell C, Hider S, Hill C, Shea B, Mackie S. 2020. Outcomes Measured in Polymyalgia Rheumatica and Measurement Properties of Instruments Considered for the OMERACT Core Outcome Set: A Systematic Review. J Rheumatol. link> doi> full text>
  • Machin AR, Babatunde O, Haththotuwa R, Scott I, Blagojevic-Bucknall M, Corp N, Chew-Graham CA, Hider SL. 2020. Correction to: The association between anxiety and disease activity and quality of life in rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol. link> doi> link> full text>
  • Machin AR, Babatunde O, Haththotuwa R, Scott I, Blagojevic-Bucknall M, Corp N, Chew-Graham CA, Hider SL. 2020. The association between anxiety and disease activity and quality of life in rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol, vol. 39(5), 1471-1482. link> doi> full text>
  • Muller S, Whittle R, Hider SL, Belcher J, Helliwell T, Morton C, Hughes E, Lawton SA, Mallen CD. 2020. Longitudinal clusters of pain and stiffness in polymyalgia rheumatica: 2-year results from the PMR Cohort Study. Rheumatology (Oxford), vol. 59(8), 1906-1915. link> doi> full text>
  • Chen WMY, Subesinghe S, Muller S, Hider SL, Mallen CD, Scott IC. 2020. The association between gravidity, parity and the risk of developing rheumatoid arthritis: A systematic review and meta-analysis. Semin Arthritis Rheum, vol. 50(2), 252-260. link> doi> full text>
  • Chean CS, Prior JA, Helliwell T, Belcher J, Mackie SL, Hider SL, Liddle J, Mallen CD. 2019. Characteristics of patients with giant cell arteritis who experience visual symptoms. Rheumatol Int, vol. 39(10), 1789-1796. link> doi> full text>
  • Sultan AA, Mallen C, Muller S, Hider S, Scott I, Helliwell T, Hall LJ. 2019. Antibiotic use and the risk of rheumatoid arthritis: a population-based case-control study. BMC Med, vol. 17(1), 154. link> doi> full text>
  • Warburton L, Hider SL, Mallen CD, Scott IC. 2019. Suspected very early inflammatory rheumatic diseases in primary care. Best Pract Res Clin Rheumatol, vol. 33(4), 101419. link> doi>
  • Hider S, Seale B, Vivekanatham A, Woods W, Chari D. 2019. INSPIRing medical undergraduates to do research: the career impacts of a summer studentship programme. The British Student Doctor Journal, vol. 3(2), 2. doi> link> full text>
  • Prior JA, Muller S, Helliwell T, Hider SL, Barraclough K, Dasgupta B, Mallen CD. 2019. The association of pain and stiffness with fatigue in incident polymyalgia rheumatica: baseline results from the polymyalgia rheumatica cohort study. Prim Health Care Res Dev, vol. 20, e46. link> doi> full text>
  • Hider SL, Muller S, Helliwell T, Prior JA, Scott I, Lawton SA, Zwierska I, van Schaardenburg D, van der Helm-van Mil A, Raza K, Mallen CD. 2019. Symptoms associated with inflammatory arthritis are common in the primary care population: results from the joint symptoms survey. Rheumatology (Oxford), vol. 58(11), 2009-2014. link> doi> full text>
  • Hider SL, Konstantinou K, Hay EM, Glossop J, Mattey DL. 2019. Inflammatory biomarkers do not distinguish between patients with sciatica and referred leg pain within a primary care population: results from a nested study within the ATLAS cohort. BMC Musculoskelet Disord, vol. 20(1), 202. link> doi> full text>
  • Morton C, Muller S, Bucknall M, Gilbert K, Mallen CD, Hider SL. 2019. Examining management and research priorities in patients with polymyalgia rheumatica: a primary care questionnaire survey. Clin Rheumatol, vol. 38(6), 1767-1772. link> doi> full text>
  • Hammad DBM, Hider SL, Liyanapathirana VC, Tonge DP. 2019. Molecular Characterization of Circulating Microbiome Signatures in Rheumatoid Arthritis. Front Cell Infect Microbiol, vol. 9, 440. link> doi> full text>
  • Ten Brinck RM, van Dijk BT, van Steenbergen HW, le Cessie S, Numans ME, Hider SL, Mallen C, van der Helm-van Mil A. 2019. Development and validation of a clinical rule for recognition of early inflammatory arthritis. BMJ Open, vol. 8(11), e023552. link> doi> full text>
  • Scott IC, Machin A, Mallen CD, Hider SL. 2018. The extra-articular impacts of rheumatoid arthritis: moving towards holistic care. BMC Rheumatol, vol. 2, 32. link> doi> full text>
  • Helliwell T, Muller S, Hider SL, Zwierska I, Lawton S, Richardson J, Mallen C. 2018. Challenges of diagnosing and managing polymyalgia rheumatica: a multi-methods study in UK general practice. Br J Gen Pract, vol. 68(676), e783-e793. link> doi>
  • Tshimologo M, Helliwell T, Hider S, Mallen C, Muller S. 2019. The availability of health information to patients with newly diagnosed polymyalgia rheumatica: results from the Polymyalgia Rheumatica (PMR) Cohort study. Prim Health Care Res Dev, vol. 20, e8. link> doi> full text>
  • Muller S, Hider S, Helliwell T, Partington R, Mallen C. 2018. The real evidence for polymyalgia rheumatic as a paraneoplastic syndrome. Reumatismo, vol. 70(2), 118-119. link> doi> full text>
  • Muller S, Hider S, Machin A, Stack R, Hayward RA, Raza K, Mallen C. 2019. Searching for a prodrome for rheumatoid arthritis in the primary care record: A case-control study in the clinical practice research datalink. Semin Arthritis Rheum, vol. 48(5), 815-820. link> doi> full text>
  • Sultan AA, Whittle R, Muller S, Roddy E, Mallen CD, Bucknall M, Helliwell T, Hider S, Paskins Z. 2018. Risk of fragility fracture among patients with gout and the effect of urate-lowering therapy. CMAJ, vol. 190(19), E581-E587. link> doi> full text>
  • Bevis M, Blagojevic-Bucknall M, Mallen C, Hider S, Roddy E. 2018. Comorbidity clusters in people with gout: an observational cohort study with linked medical record review. Rheumatology (Oxford), vol. 57(8), 1358-1363. link> doi> full text>
  • Scott IC, Mangat N, MacGregor A, Raza K, Mallen CD, Hider SL. 2018. Primary care challenges in diagnosing and referring patients with suspected rheumatoid arthritis: a national cross-sectional GP survey. Rheumatol Adv Pract, vol. 2(1), rky012. link> doi> full text>
  • Muller S, Hider S, Helliwell T, Partington R, Mallen C. 2018. The real evidence for polymyalgia rheumatica as a paraneoplastic syndrome. Reumatismo, vol. 70(1), 23-34. link> doi> full text>
  • Paskins Z, Whittle R, Abdul Sultan A, Muller S, Blagojevic-Bucknall M, Helliwell T, Packham J, Hider S, Roddy E, Mallen C. 2018. Risk of fragility fracture among patients with late-onset psoriasis: a UK population-based study. Osteoporos Int, vol. 29(7), 1659-1664. link> doi> full text>
  • Scott IC, Hider SL, Scott DL. 2018. Thromboembolism with Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis: How Real is the Risk?. Drug Safety. link> doi> link> full text>
  • Helliwell T, Muller S, Hider SL, Prior JA, Richardson JC, Mallen CD. 2018. Challenges of diagnosis and management of giant cell arteritis in general practice: a multimethods study. BMJ Open, vol. 8(2), e019320. link> doi> full text>
  • Paskins Z, Whittle R, Sultan AA, Muller S, Blagojevic-Bucknall M, Helliwell T, Hider S, Roddy E, Mallen C. 2018. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study. BMC Med, vol. 16(1), 4. link> doi> full text>
  • Chandratre P, Mallen C, Richardson J, Muller S, Hider S, Rome K, Blagojevic-Bucknall M, Roddy E. 2018. Health-related quality of life in gout in primary care: Baseline findings from a cohort study. Semin Arthritis Rheum, vol. 48(1), 61-69. link> doi> full text>
  • Hider SL, Bucknall M, Cooke K, Cooke K, Finney AG, Goddin D, Healey EL, Hennings S, Herron D, Jinks C, Lewis M, Machin A, Mallen C, Wathall S, Chew-Graham CA. 2018. The INCLUDE study: INtegrating and improving Care for patients with infLammatory rheUmatological DisordErs in the community; identifying multimorbidity: Protocol for a pilot randomized controlled trial. J Comorb, vol. 8(1), 2235042X18792373. link> doi> full text>
  • Clarson LE, Hider SL, Belcher J, Roddy E, Mallen CD. 2017. Factors Influencing Allopurinol Initiation in Primary Care. Ann Fam Med, vol. 15(6), 557-560. link> doi>
  • Machin A, Hider S, Dale N, Chew-Graham C. 2017. Improving recognition of anxiety and depression in rheumatoid arthritis: a qualitative study in a community clinic. Br J Gen Pract, vol. 67(661), e531-e537. link> doi> full text>
  • Cawley A, Prior JA, Muller S, Helliwell T, Hider SL, Dasgupta B, Barraclough K, Mallen CD. 2018. Association between characteristics of pain and stiffness and the functional status of patients with incident polymyalgia rheumatica from primary care. Clin Rheumatol, vol. 37(6), 1639-1644. link> doi> full text>
  • Vivekanantham A, Blagojevic-Bucknall M, Clarkson K, Belcher J, Mallen CD, Hider SL. 2018. How common is depression in patients with polymyalgia rheumatica?. Clin Rheumatol, vol. 37(6), 1633-1638. link> doi>
  • Roddy E, Muller S, Paskins Z, Hider SL, Blagojevic-Bucknall M, Mallen CD. 2017. Incident acute pseudogout and prior bisphosphonate use: Matched case-control study in the UK-Clinical Practice Research Datalink. Medicine (Baltimore), vol. 96(12), e6177. link> doi> full text>
  • Vivekanantham A, Protheroe J, Muller S, Hider S. 2017. Evaluating on-line health information for patients with polymyalgia rheumatica: a descriptive study. BMC Musculoskelet Disord, vol. 18(1), 43. link> doi> full text>
  • Tshimologo M, Saunders B, Muller S, Mallen CD, Hider SL. 2017. Patients' views on the causes of their polymyalgia rheumatica: a content analysis of data from the PMR Cohort Study. BMJ Open, vol. 7(1), e014301. link> doi> full text>
  • Masson W, Muller S, Whittle R, Prior J, Helliwell T, Mallen C, Hider SL. 2017. Possible giant cell arteritis symptoms are common in newly diagnosed patients with Polymyalgia Rheumatica: results from an incident primary care PMR cohort. BMC Rheumatol, vol. 1, 7. link> doi> full text>
  • Roddy E, Jordan KP, Oppong R, Chen Y, Jowett S, Dawes P, Hider SL, Packham J, Stevenson K, Zwierska I, Hay EM. 2016. Reconsultation, self-reported health status and costs following treatment at a musculoskeletal Clinical Assessment and Treatment Service (CATS): a 12-month prospective cohort study. BMJ Open, vol. 6(10), e011735. link> doi> full text>
  • Muller S, Hider SL, Helliwell T, Lawton S, Barraclough K, Dasgupta B, Zwierska I, Mallen CD. 2016. Characterising those with incident polymyalgia rheumatica in primary care: results from the PMR Cohort Study. Arthritis Res Ther, vol. 18, 200. link> doi> full text>
  • Ahmed N, Prior JA, Chen Y, Hayward R, Mallen CD, Hider SL. 2016. Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study. Clin Rheumatol, vol. 35(12), 3069-3073. link> doi> full text>
  • Richardson JC, Liddle J, Mallen CD, Roddy E, Hider S, Prinjha S, Ziebland S. 2016. A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout. BMC Musculoskelet Disord, vol. 17, 249. link> doi> full text>
  • Muller S, Hider SL, Mallen CD. 2016. The Importance of Linking Primary and Secondary Electronic Medical Records. J Rheumatol, vol. 43(6), 1252. link> doi>
  • Muller S, Hider SL, Raza K, Stack RJ, Hayward RA, Mallen CD. 2015. An algorithm to identify rheumatoid arthritis in primary care: a Clinical Practice Research Datalink study. BMJ Open, vol. 5(12), e009309. link> doi> full text>
  • Richardson JC, Liddle J, Mallen CD, Roddy E, Prinjha S, Ziebland S, Hider S. 2015. "Why me? I don't fit the mould … I am a freak of nature": a qualitative study of women's experience of gout. BMC Womens Health, vol. 15, 122. link> doi> full text>
  • Hider SL, Blagojevic-Bucknall M, Whittle R, Clarkson K, Mangat N, Stack R, Raza K, Mallen CD. 2015. What does a primary care annual review for RA include? A national GP survey. Clinical rheumatology, vol. 35(8), 2137-2138. doi> link> full text>
  • Liddle J, Roddy E, Mallen CD, Hider SL, Prinjha S, Ziebland S, Richardson JC. 2015. Mapping patients' experiences from initial symptoms to gout diagnosis: a qualitative exploration. BMJ Open, vol. 5(9), e008323. link> doi> full text>
  • Roddy E, Muller S, Rome K, Chandratre P, Hider SL, Richardson J, Blagojevic-Bucknall M, Mallen CD. 2015. Foot problems in people with gout in primary care: baseline findings from a prospective cohort study. J Foot Ankle Res, vol. 8, 31. link> doi> full text>
  • Clarson LE, Hider SL, Belcher J, Heneghan C, Roddy E, Mallen CD. 2015. Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink. Ann Rheum Dis, vol. 74(4), 642-647. link> doi> full text>
  • Clarson LE, Chandratre P, Hider SL, Belcher J, Heneghan C, Roddy E, Mallen CD. 2015. Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis. Eur J Prev Cardiol, vol. 22(3), 335-343. link> doi> full text>
  • Szkornik L, Beardmore R, Boylan J, Hider S, Hunter SM, Montana-Williams K, Morgan C, Sherman S, Watts J. 2015. The Aurora Women's Leadership Programme: reflections from the inaugural Keele cohort. Journal of Academic Development and Education, vol. 3, 54-57.
  • Green DJ, Muller S, Mallen CD, Hider SL. 2015. Fatigue as a precursor to polymyalgia rheumatica: an explorative retrospective cohort study. Scand J Rheumatol, vol. 44(3), 219-223. link> doi>
  • Clarson L, Hider SL, Belcher J, Heneghan C, Roddy E, Mallen CD. 2015. Response to: 'Risk of vascular disease with gout: overadjustment of the statistical analyses?' by van Durme et al. Ann Rheum Dis, vol. 74(1), e10. link> doi>
  • Roddy E, Muller S, Paskins Z, Hider S, Blagojevic-Bucknall M, Mallen C. 2014. Bisphosphonates and Risk of Acute Pseudogout: A Case-Control Study in the Clinical Practice Research Datalink (CPRD). ARTHRITIS & RHEUMATOLOGY, vol. 66, S366. link>
  • Muller S, Hider SL, Belcher J, Helliwell T, Mallen CD. 2014. Is cancer associated with polymyalgia rheumatica? A cohort study in the General Practice Research Database. Ann Rheum Dis, vol. 73(10), 1769-1773. link> doi> full text>
  • Hancock AT, Mallen CD, Muller S, Belcher J, Roddy E, Helliwell T, Hider SL. 2014. Risk of vascular events in patients with polymyalgia rheumatica. CMAJ, vol. 186(13), E495-E501. link> doi>
  • Ellerby N, Mattey DL, Packham J, Dawes P, Hider SL. 2014. Obesity and comorbidity are independently associated with a failure to achieve remission in patients with established rheumatoid arthritis. Ann Rheum Dis, vol. 73(11), e74. link> doi>
  • Hider SL, Whitehurst DGT, Thomas E, Foster NE. 2015. Pain location matters: the impact of leg pain on health care use, work disability and quality of life in patients with low back pain. Eur Spine J, vol. 24(3), 444-451. link> doi>
  • Chari DM and Hider S. 2014. Developing the Keele Medical Research Pathway: Challenges For a Young Medical School. Midlands Medicine, vol. 27(3), 140.
  • Hayward RA, Rathod T, Muller S, Hider SL, Roddy E, Mallen CD. 2014. Association of polymyalgia rheumatica with socioeconomic status in primary care: a cross-sectional observational study. Arthritis Care Res (Hoboken), vol. 66(6), 956-960. link> doi>
  • Chandratre P, Roddy E, Clarson L, Richardson J, Hider SL, Mallen CD. 2013. Health-related quality of life in gout: a systematic review. RHEUMATOLOGY, vol. 52(11), 2031-2040. link> doi>
  • Monk HL, Muller S, Mallen CD, Hider SL. 2013. Cardiovascular screening in rheumatoid arthritis: a cross-sectional primary care database study. BMC Fam Pract, vol. 14, 150. link> doi>
  • Hayward RA, Rathod T, Roddy E, Muller S, Hider SL, Mallen CD. 2013. The association of gout with socioeconomic status in primary care: a cross-sectional observational study. Rheumatology (Oxford), vol. 52(11), 2004-2008. link> doi>
  • Helliwell T, Muller S, Hider SL, Mallen CD. 2013. HOW GENERAL PRACTITIONERS DIAGNOSE POLYMYALGIA RHEUMATICA. ANNALS OF THE RHEUMATIC DISEASES, vol. 72, 155. link>
  • Helliwell T, Muller S, Hider SL, Mallen CD. 2013. HOW GENERAL PRACTITIONERS DIAGNOSE POLYMYALGIA RHEUMATICA. ANNALS OF THE RHEUMATIC DISEASES, vol. 72, 1044. link>
  • Hider S, Muller S, Roddy E, Mallen C. 2013. POLYMYALGIA RHEUMATICA: IS IT UNDER-REPRESENTED AT RHEUMATOLOGY CONFERENCES?. ANNALS OF THE RHEUMATIC DISEASES, vol. 72, 1005. link>
  • Helliwell T, Hider SL, Mallen CD. 2013. Polymyalgia rheumatica: diagnosis, prescribing, and monitoring in general practice. Br J Gen Pract, vol. 63(610), e361-e366. link> doi>
  • Roddy E, Zwierska I, Jordan KP, Dawes P, Hider SL, Packham J, Stevenson K, Hay EM. 2013. Musculoskeletal clinical assessment and treatment services at the primary-secondary care interface: an observational study. Br J Gen Pract, vol. 63(607), e141-e148. link> doi>
  • Konstantinou K, Hider SL, Jordan JL, Lewis M, Dunn KM, Hay EM. 2013. The impact of low back-related leg pain on outcomes as compared with low back pain alone: a systematic review of the literature. Clin J Pain, vol. 29(7), 644-654. link> doi>
  • Chandratre P, Mallen C, Richardson J, Rome K, Bailey J, Gill R, Hider S, Mason J, Mayson Z, Muller S, Purcell C, Titley J, Wathall S, Zwierska I, Roddy E. 2012. Prospective observational cohort study of Health Related Quality of Life (HRQOL), chronic foot problems and their determinants in gout: a research protocol. BMC Musculoskelet Disord, vol. 13, 219. link> doi>
  • Hancock AT, Mallen CD, Belcher J, Hider SL. 2012. Association between polymyalgia rheumatica and vascular disease: a systematic review. Arthritis Care Res (Hoboken), vol. 64(9), 1301-1305. link> doi>
  • Helliwell T, Hider S, Barraclough K, Dasgupta B, Mallen C. 2012. Diagnosis and management of polymyalgia rheumatica Response. BRITISH JOURNAL OF GENERAL PRACTICE, vol. 62(600), 348. link> doi>
  • Muller S, Hider S, Helliwell T, Bailey J, Barraclough K, Cope L, Dasgupta B, Foskett R, Hughes R, Mayson Z, Purcell C, Roddy E, Wathall S, Zwierska I, Mallen CD. 2012. The epidemiology of polymyalgia rheumatica in primary care: a research protocol. BMC Musculoskelet Disord, vol. 13, 102. link> doi> full text>
  • Barraclough K, Mallen CD, Helliwell T, Hider SL, Dasgupta B. 2012. Diagnosis and management of giant cell arteritis. Br J Gen Pract, vol. 62(599), 329-330. link> doi>
  • Helliwell T, Hider SL, Barraclough K, Dasgupta B, Mallen CD. 2012. Diagnosis and management of polymyalgia rheumatica. Br J Gen Pract, vol. 62(598), 275-276. link> doi>
  • Owen SA, Hider SL, Martin P, Bruce IN, Barton A, Thomson W. 2013. Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients. Pharmacogenomics J, vol. 13(3), 227-234. link> doi>
  • Helliwell T, Muller S, Hider S. 2012. RAISED INFLAMMATORY MARKERS ESR can be normal in giant cell arteritis and polymyalgia rheumatica. BRITISH MEDICAL JOURNAL, vol. 344, Article ARTN e1408. link> doi>
  • Konstantinou K, Beardmore R, Dunn KM, Lewis M, Hider SL, Sanders T, Jowett S, Somerville S, Stynes S, van der Windt DAWM, Vogel S, Hay EM. 2012. Clinical course, characteristics and prognostic indicators in patients presenting with back and leg pain in primary care. The ATLAS study protocol. BMC Musculoskelet Disord, vol. 13, 4. link> doi> full text>
  • Muller S, Hider SL, Helliwell T, Mallen CD. 2012. An unorthodox approach to calculating sample size. BMJ, vol. 345, e6586. link> doi>
  • Helliwell T, Muller S, Hider S. 2012. ESR can be normal in giant cell arteritis and polymyalgia rheumatica. BMJ, vol. 344, e1408. link> doi>
  • Helliwell T, Muller S, Hider SL. 2012. ESR can be normal in giant cell arthritis and polymyalgia rheumatica. BMJ, vol. 344, e1408.
  • Chandratre P, Mallen C, Richardson J, Rome K, Bailey J, Gill R, Hider SL, Mason J, Mayson Z, Muller S, Purcell C, Titley J, Wathall S, Zwierska I, Roddy E. 2012. Prospective observational cohort study of Health Related Quality of Life (HRQOL), chronic foot problems and their determinants in gout: a research protocol. BMC Musculoskelet Disord, vol. 13(1), 219.
  • Konstantinou K, Hider SL, Vogel S, Beardmore R, Somerville S. 2012. Development of an assessment schedule for patients with low back-associated leg pain in primary care: a Delphi consensus study. Eur Spine J, vol. 21(7), 1241-1249. link> doi> full text>
  • Owen SA, Lunt M, Bowes J, Hider SL, Bruce IN, Thomson W, Barton A. 2013. MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms. Pharmacogenomics J, vol. 13(2), 137-147. link> doi>
  • Kapoor SR, Hider SL, Brownfield A, Mattey DL, Packham JC. 2011. Fibromyalgia in patients with rheumatoid arthritis: driven by depression or joint damage?. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, vol. 29(6), S88-S91. link>
  • Reilly M, Wellcome Trust Case Control Consortium, Hider SL. 2011. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet Infectious Diseases, vol. 377(9763), 383-392.
  • Owen SA, Lunt M, Hider SL, Bruce IN, Barton A, Thomson W. 2010. Testing pharmacogenetic indices to predict efficacy and toxicity of methotrexate monotherapy in a rheumatoid arthritis patient cohort. Arthritis Rheum, vol. 62(12), 3827-3829. link> doi>
  • Roddy E, Zwierska I, Dawes P, Hider SL, Jordan KP, Packham J, Stevenson K, Hay E, SAMBA team. 2010. The Staffordshire arthritis, musculoskeletal, and back assessment (SAMBA) study: a prospective observational study of patient outcome following referral to a primary-secondary care musculoskeletal interface service. BMC Musculoskelet Disord, vol. 11, 67. link> doi>
  • Roddy E, Mallen CD, Hider SL, Jordan KP. 2010. Prescription and comorbidity screening following consultation for acute gout in primary care. Rheumatology (Oxford), vol. 49(1), 105-111. link> doi>
  • Hider SL, Tanveer W, Brownfield A, Mattey DL, Packham JC. 2009. Depression in RA patients treated with anti-TNF is common and under-recognized in the rheumatology clinic. Rheumatology (Oxford), vol. 48(9), 1152-1154. link> doi> full text>
  • Pemberton PW, Ahmad Y, Bodill H, Lokko D, Hider SL, Yates AP, Walker MG, Laing I, Bruce IN. 2009. Biomarkers of oxidant stress, insulin sensitivity and endothelial activation in rheumatoid arthritis: a cross-sectional study of their association with accelerated atherosclerosis. BMC Res Notes, vol. 2, 83. link> doi>
  • Hider SL, Silman AJ, Thomson W, Lunt M, Bunn D, Symmons DPM. 2009. Can clinical factors at presentation be used to predict outcome of treatment with methotrexate in patients with early inflammatory polyarthritis?. Ann Rheum Dis, vol. 68(1), 57-62. link> doi>
  • Hider SL, Thomson W, Mack LF, Armstrong DJ, Shadforth M, Bruce IN. 2008. Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX. Rheumatology (Oxford), vol. 47(8), 1156-1159. link> doi>
  • Hider SL. 2008. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet, vol. 40(6), 768-775.
  • Hider SL. 2008. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's Disease. Nat Genet, vol. 40(6), 710-712.
  • HIDER SL, Thomson W, Bruce IN. 2008. Response to Dr Van der Kooiji et al re: The pharmacogenetics of methotrexate. Rheumatology, vol. 47(4), 557-558.
  • Hider SL, Bruce IN, Thomson W. 2007. The pharmacogenetics of methotrexate. Rheumatology (Oxford), vol. 46(10), 1520-1524. link> doi>
  • Hider SL. 2007. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet, vol. 39(11), 1329-1337. doi>
  • Hider SL. 2007. Rheumatoid arthritis association at 6q23. Nat Genet, vol. 39(12), 1431-1433.
  • Hider SL, Silman A, Bunn D, Manning S, Symmons D, Lunt M. 2006. Comparing the long-term clinical outcome of treatment with methotrexate or sulfasalazine prescribed as the first disease-modifying antirheumatic drug in patients with inflammatory polyarthritis. Ann Rheum Dis, vol. 65(11), 1449-1455. link> doi>
  • Hider SL, Owen A, Hartkoorn R, Khoo S, Back D, Silman AJ, Bruce IN. 2006. Down regulation of multidrug resistance protein-1 expression in patients with early rheumatoid arthritis exposed to methotrexate as a first disease-modifying antirheumatic drug. Ann Rheum Dis, vol. 65(10), 1390-1393. link> doi>
  • Hider SL, Woodhead M, Taylor PM, Bruce IN. 2006. Lung fibrosis in systemic sclerosis treated with a combination of ciclosporin and azathioprine. Clin Exp Rheumatol, vol. 24(2), 215. link>
  • Hider SL, Hoggard P, Khoo S, Back D, Bruce IN. 2005. Drug efflux transporters in rheumatoid arthritis: comment on the article by Kremer. Arthritis Rheum, vol. 52(2), 670. link> doi>
  • Hider SL, Bruce IN, Silman AJ, Symmons DPM. 2005. Defining response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis. J Rheumatol, vol. 32(1), 6-10. link>
  • Hider SL, Ismail A, Todd B, Rodgers J, Hamilton A, Cook G. 2005. Does a patient-focused approach increase prescribing following a low trauma fracture?. Rheumatology (Oxford), vol. 44(1), 138-139. link> doi>
  • Hider SL, Buckley C, Silman AJ, Symmons DPM, Bruce IN. 2005. Factors influencing response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis. J Rheumatol, vol. 32(1), 11-16. link>
  • Hider SL, Roy DK, Augustine T, Parrott N, Bruce IN. 2004. Resolution of diabetic cheiroarthropathy after pancreatic transplantation. Diabetes Care, vol. 27(9), 2279-2280. link> doi>
  • Hider SL, Ismail AA, Cook G, Todd B, Rogers J, Hamilton A. 2004. PRESCRIBING FOLLOWING OSTEOPOROTIC FRACTURE: DOES A PATIENT AND GENERAL PRACTITIONER CENTRED APPROACH INCREASE PRESCRIBING?. RHEUMATOLOGY, vol. 43, 82. link>
  • Dornan T, Boshuizen E, Cordingley L, Hider S, Hadfield J, Scherpier A. 2004. Evaluation of self directed clinical education: validation of an instrument. Medical Education, vol. 38(6), 670-678.
  • Hider SL, Morgan C, Bell E, Bruce IN. 2003. Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with RA?. Ann Rheum Dis, vol. 62(6), 591. link> doi>
  • Harrison BJ, Silman AJ, Hider SL, Herrick AL. 2002. Cigarette smoking as a significant risk factor for digital vascular disease in patients with systemic sclerosis. Arthritis Rheum, vol. 46(12), 3312-3316. link> doi>
  • Hider SL, Hilton RC, Hutchinson C. 2002. Chronic exertional compartment syndrome as a cause of bilateral forearm pain. Arthritis Rheum, vol. 46(8), 2245-2246. link> doi>
  • Hider SL, Mulherin D, Ortiz M, Wong M. 2002. Exercise and body image in ankylosing spondylitis. Scandinavian Journal of Rheumatology, vol. 31, 168-171.
  • Hider SL, Lunt M, Herrick AL. 2001. Amputations in systemic sclerosis: the influence of disease subtype, anticentromere antibody and smoking status. RHEUMATOLOGY, vol. 40, 116. link>
  • Hider SL, Mulherin D, Ortiz M, Wong M. 2001. Exercise and body image in ankylosing spondylitis. RHEUMATOLOGY, vol. 40, 40-41. link>
  • Bradbury SL and Scarpello JHB. 1999. Recurrent hypoglycaemia as the presenting symptom of coeliac disease in a patient with type 1 diabetes. Practical Diabetes International 16, vol. 16(3), 89-90.

Chapters

  • Hider SL, Morgan C, Thomson W, Bruce IN. 2006. Pharmacogenetics in Rheumatology. In Pharmacogenetics. Hall (Ed.).

Other

  • Hendry GJ, Bearne L, Foster N, Godfrey E, Hider S, van der Leeden M, Mason H, McConnachie A, McInnes I, Patience A, Sackley C, Sekhon M, Williams A, Woodburn J, Steultjens M. 2020. A MIXED METHODS FEASIBILITY STUDY OF A GAIT REHABILITATION PROGRAMME FOR PEOPLE WITH EARLY RHEUMATOID ARTHRITIS AND FOOT PAIN. RHEUMATOLOGY (vol. 59, p. 64). link> doi>
  • Watson L, Belcher J, Nicholls E, Chandratre P, Blagojevic-Bucknall M, Hider S, Lawton SA, Mallen CD, Muller S, Rome K, Roddy E. 2020. FACTORS ASSOCIATED WITH CHANGE IN HEALTH-RELATED QUALITY OF LIFE IN PEOPLE LIVING WITH GOUT: A THREE-YEAR PROSPECTIVE COHORT STUDY IN PRIMARY CARE. RHEUMATOLOGY (vol. 59). link> doi>
  • Feddah H, Muller S, Hider S, Hay C, Mallen C. 2020. GASTROINTESTINAL SYMPTOMS AND PROTON PUMP INHIBITOR USE IN PATIENTS WITH POLYMYALGIA RHEUMATICA: RESULTS FROM THE PMR COHORT STUDY. RHEUMATOLOGY (vol. 59). link> doi>
  • Scott IC, Bajpai R, Hider SL, Helliwell T, Muller S, Mallen C. 2020. The relationship between obesity and outcomes in patients with polymyalgia rheumatica. Rheumatology. link> doi>
  • Scott IC, Bajpai R, Hider SL, Helliwell T, Muller S, Mallen CD. 2020. THE RELATIONSHIP BETWEEN OBESITY AND OUTCOMES IN PATIENTS WITH POLYMYALGIA RHEUMATICA. RHEUMATOLOGY (vol. 59, p. 18). link> doi>
  • Sekhon M, Godfrey E, Hendry G, Foster NE, Hider S, van der Leeden M, Mason H, McConnachie A, McInnes I, Patience A, Sackley C, Steultjens M, Williams A, Woodburn J, Bearne L. 2020. THERAPISTS ACCEPTABILITY OF DELIVERING A PSYCHOLOGICALLY INFORMED GAIT REHABILITATION INTERVENTION IN EARLY RHEUMATOID ARTHRITIS (GREAT): A QUALITATIVE INTERVIEW STUDY. RHEUMATOLOGY (vol. 59). link> doi>
  • Godfrey E, Sekhon M, Hendry G, Foster NE, Hider S, van der Leeden M, Mason H, McConnachie A, McInnes I, Patience A, Sackley C, Steultjens M, Williams A, Woodburn J, Bearne L. 2020. TREATMENT FIDELITY IN THE GAIT REHABILITATION IN EARLY RHEUMATOID ARTHRITIS TRIAL (GREAT) FEASIBILITY STUDY. RHEUMATOLOGY (vol. 59). link> doi>
  • Hider S, Machin A, Bucknall M, Cooke K, Jinks C, Healey E, Finney A, Cooke K, Wathall S, Mallen C, Chew-Graham C. 2020. UNDERTAKING AN INTEGRATED NURSE LED REVIEW (INCLUDE) FOR PATIENTS WITH INFLAMMATORY CONDITIONS: DOES IT CHANGE MANAGEMENT OF MORBIDITIES?. RHEUMATOLOGY (vol. 59). link> doi>
  • Hawarden AW, Paskins Z, Desilva EE, Herron D, Machin A, Jinks C, Hider S, Chew-Graham C. 2020. EXPERIENCES OF DELIVERING A NURSE-LED FRACTURE RISK ASSESSMENT FOR PATIENTS WITH INFLAMMATORY RHEUMATOLOGICAL CONDITIONS IN PRIMARY CARE. RHEUMATOLOGY (vol. 59). link>
  • Twomlow EL, Prior JA, Mackie SL, Helliwell T, Hider SL, Belcher J, Liddle J, Mallen CD. 2019. CHARACTERISTICS OF PATIENTS WITH PREVALENT GIANT CELL ARTERITIS IN UK PRIMARY CARE. RHEUMATOLOGY (vol. 58, p. 130). link> doi>
  • Morton C, Muller S, Hider S, Belcher J, Mallen CD, Helliwell T. 2019. PREDICTING DURATION OF GLUCOCORTICOID THERAPY IN AN INCEPTION COHORT OF PATIENTS WITH POLYMYALGIA RHEUMATICA. RHEUMATOLOGY (vol. 58, p. 176). link> doi>
  • Machin AR, Hider SL, Jinks C, Herron D, Paskins Z, Cooke K, Chew-Graham CA. 2019. DEVELOPMENT OF A NURSE-LED INTEGRATED CARE REVIEW BASED IN PRIMARY CARE TO IDENTIFY AND IMPROVE THE MANAGEMENT OF CO-MORBIDITIES IN PATIENTS WITH INFLAMMATORY RHEUMATOLOGICAL CONDITIONS: THE INCLUDE STUDY. RHEUMATOLOGY (vol. 58). link>
  • Machin AR, Haththotuwa R, Babatunde O, Scott I, Bucknall M, Corp N, Chew-Graham CA, Hider SL. 2019. THE IMPACT OF ANXIETY ON QUALITY OF LIFE AND DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW. RHEUMATOLOGY (vol. 58, p. 78). link>
  • Machin AR, Hider SL, Chew-Graham CA, Bucknall M. 2019. THE INCIDENCE OF ANXIETY OR DEPRESSION IN PATIENTS WITH AND WITHOUT INFLAMMATORY RHEUMATIC CONDITIONS. RHEUMATOLOGY (vol. 58). link>
  • Hay CA, Prior JA, Scott I, Raza K, Hider S, Mallen CD. 2018. DIAGNOSTIC DELAY FOR RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW. ANNALS OF THE RHEUMATIC DISEASES (vol. 77, p. 1290). link> doi>
  • Grose-Hodge E, Scott I, Dale N, Ryan S, Machin A, Hider S. 2018. PREVALENCE OF IMPAIRED HEALTH LITERACY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ITS ASSOCIATION WITH MEDICATION UNDERSTANDING AND PATIENT OUTCOMES. RHEUMATOLOGY (vol. 57). link>
  • Muller S, Hider S, Machin A, Stack R, Hayward R, Raza K, Mallen C. 2018. SEARCHING FOR A PRODROME FOR RHEUMATOID ARTHRITIS IN THE PRIMARY CARE RECORD: A CLINICAL PRACTICE RESEARCH DATALINK STUDY. RHEUMATOLOGY (vol. 57). link>
  • Yates M, Galloway J, Snowden N, Norton S, Macgregor AJ, Rivett A, Souto M, Dennison EM, Hider SL, Ledingham JM. 2018. THE IMPACT OF THE EIA CLINIC ON EARLY RA CARE. RHEUMATOLOGY (vol. 57). link>
  • Hider SL, Ryan S, Dale N, Stanyer N, Machin A, Chew-Graham CA. 2017. ASSESSING DEPRESSION IN PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS-HOW DO DIFFERENT APPROACHES COMPARE?. ANNALS OF THE RHEUMATIC DISEASES (vol. 76, p. 1174). link> doi>
  • Hider SL, Blagojevic-Bucknall M, Muller S, Clarkson K, Mallen C. 2017. ASSESSMENT OF AGREEMENT BETWEEN SELF-REPORT INFLAMMATORY ARTHRITIS SYMPTOMS AND CORRESPONDING GP DIAGNOSIS IN PATIENTS WITH PMR. ANNALS OF THE RHEUMATIC DISEASES (vol. 76, p. 1442). link> doi>
  • Higginbottom A, Blackburn S, Campbell L, Rhodes C, Taylor R, Machin A, Hider S, Roddy E, Chew-Graham CA, Dziedzic K. 2017. CELEBRATING TEN YEARS OF SUCCESSFUL PATIENT INVOLVEMENT IN RESEARCH OF INFLAMMATORY CONDITIONS. ANNALS OF THE RHEUMATIC DISEASES (vol. 76, p. 1551). link> doi>
  • Sultan AA, Whittle R, Muller S, Roddy E, Mallen C, Blagojevic-Bucknall M, Helliwell T, Hider S, Paskins Z. 2017. RISK OF FRACTURE AMONG PATIENTS WITH GOUT: A POPULATION-BASED COHORT STUDY. ANNALS OF THE RHEUMATIC DISEASES (vol. 76, p. 751). link> doi>
  • Paskins Z, Whittle R, Sultan AA, Muller S, Blagojevic-Bucknall M, Helliwell T, Hider S, Roddy E, Mallen C. 2017. RISK OF FRAGILITY FRACTURE AMONG PATIENTS WITH PSORIASIS: A POPULATION BASED MATCHED COHORT STUDY FROM THE UNITED KINGDOM. ANNALS OF THE RHEUMATIC DISEASES (vol. 76, pp. 1028-1029). link> doi>
  • Hider SL, Muller S, Prior J, Helliwell T, Van Schaardenburg D, van der Helm-van Mil A, Raza K, Mallen CD. 2017. SYMPTOMS INDICATIVE OF INFLAMMATORY ARTHRITIS ARE COMMON IN THE PRIMARY CARE POPULATION: FINDINGS FROM THE SYMPTOMS IN PERSONS AT RISK OF RHEUMATOID ARTHRITIS SURVEY. ANNALS OF THE RHEUMATIC DISEASES (vol. 76, p. 1043). link> doi>
  • Liddle J, Richardson JC, Mallen CD, Hider SL, Chandratre P, Roddy E. 2017. I FOUND IT MOST CONFUSING, I DIDN'T KNOW WHAT TO BELIEVE: EXPLORING PATIENT DECISION MAKING AROUND GOUT AND DIET. RHEUMATOLOGY (vol. 56, p. 121). link>
  • Machin AR, Chew-Graham CA, Dale N, Ryan S, Hider S. 2017. PERSPECTIVES OF PATIENTS WITH RHEUMATOID ARTHRITIS ON CASE-FINDING FOR ANXIETY AND DEPRESSION WITHIN A NURSE-LED ANNUAL REVIEW CLINIC. RHEUMATOLOGY (vol. 56, p. 127). link>
  • Paskins Z, Whittle R, Hider S, Sultan AA, Bucknall M, Helliwell T, Roddy E, Mallen CD. 2017. RISK OF FRAGILITY FRACTURE OVER 10 YEARS IN POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS: A UK POPULATION STUDY. RHEUMATOLOGY (vol. 56, pp. 85-86). link>
  • Paskins Z, Whittle R, Hider S, Sultan AA, Edward R, Mallen C. 2016. RISK OF FRAGILITY FRACTURE OVER 10 YEARS ACROSS EIGHT INFLAMMATORY CONDITIONS: A UK POPULATION STUDY. OSTEOPOROSIS INTERNATIONAL (vol. 27, pp. 616-617). link>
  • Hider S, Morton C, Muller S, Belcher J, Gilbert K, Bucknall M, Mallen C. 2016. PATIENT PRIORITIES FOR PMR RESEARCH: A PRIMARY CARE SURVEY. ANNALS OF THE RHEUMATIC DISEASES (vol. 75, p. 169). link> doi>
  • Mangat NS, Raza K, Clarkson K, Stack R, Mallen C, Belcher J, Hider S. 2016. CHALLENGES FACED IN PRIMARY CARE DURING THE EARLY STAGES OF RHEUMATOID ARTHRITIS: A CROSS-SECTIONAL SURVEY OF GENERAL PRACTITIONERS. RHEUMATOLOGY (vol. 55, p. 78). link>
  • Muller S, Masson W, Hider SL, Helliwell T, Lawton S, Prior J, Zwierska I, Barraclough K, Dasgupta B, Mallen CD. 2016. HOW COMMON ARE GIANT CELL ARTERITIS SYMPTOMS IN PATIENTS WITH POLYMYALGIA RHEUMATICA? RESULTS FROM AN INCIDENT PRIMARY CARE COHORT. RHEUMATOLOGY (vol. 55, p. 77). link>
  • Rashid M, Mattey D, Glossop J, Kamath S, Hider S. 2016. HOW COMMON IS CHRONIC KIDNEY DISEASE IN A COHORT OF PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS?. RHEUMATOLOGY (vol. 55, p. 86). link>
  • Tshimologo M, Saunders B, Muller S, Mallen CD, Hider SL. 2016. PATIENT'S VIEWS ON THE CAUSES OF THEIR POLYMYALGIA RHEUMATICA: RESULTS FROM THE PMR COHORT STUDY. RHEUMATOLOGY (vol. 55, pp. 79-80). link> full text>
  • Prior JA, Muller S, Helliwell T, Hider S, Dasgupta B, Mallen CD. 2016. THE ROLE OF PAIN AND STIFFNESS ON FATIGUE AND INSOMNIA IN AN INCIDENT POLYMYALGIA RHEUMATICA COHORT. RHEUMATOLOGY (vol. 55, p. 82). link>
  • Zhao S, Hider S, Sparks C, Matcham F, Galloway J, Estrach C, Goodson N. 2015. Association Between Anxiety and Depression and Rheumatoid Arthritis Outcome: Results from an Inception Early Rheumatoid Arthritis Cohort. ARTHRITIS & RHEUMATOLOGY (vol. 67). link>
  • Matcham F, Norton S, Goodson N, Hider S, Hotopf M, Galloway J. 2015. Association Between Anxiety and Depression and Rheumatoid Disease Severity: Results from an Established Rheumatoid Arthritis Cohort. ARTHRITIS & RHEUMATOLOGY (vol. 67). link>
  • Hider S, Konstantinou K, Mattey DL, Hay EM. 2015. ARE SERUM BIOMARKER LEVELS ASSOCIATED WITH SCIATICA?. ANNALS OF THE RHEUMATIC DISEASES (vol. 74, p. 629). link> doi>
  • Hider S. 2015. CASE 1 PRESENTATION: WHAT SYMPTOMS DO GPS SEE AND WHAT DO THEY DO?. ANNALS OF THE RHEUMATIC DISEASES (vol. 74, p. 26). link> doi>
  • Bevis M, Blagojevic-Bucknall M, Mallen CD, Hider SL, Roddy E. 2015. COMORBIDITY CLUSTERS IN PEOPLE WITH GOUT: A PRIMARY CARE BASED OBSERVATIONAL STUDY. RHEUMATOLOGY (vol. 54, p. 152). link>
  • Clarson LE, Hider SL, Belcher J, Roddy E, Heneghan C, Mallen CD. 2015. GOUT AND RISK OF SUBSEQUENT VASCULAR EVENT: A DISCRETE-TIME EVENT HISTORY ANALYSIS IN THE CLINICAL PRACTICE RESEARCH DATALINK. RHEUMATOLOGY (vol. 54, p. 38). link> doi>
  • Helliwell T, Muller S, Hider SL, Richardson J, Mallen C. 2015. HOW DO GENERAL PRACTITIONERS MANAGE SUSPECTED GIANT CELL ARTERITIS. RHEUMATOLOGY (vol. 54, p. 168). link>
  • Hider S, Blagojevic-Bucknall M, Case R, Clarkson K, Stack R, Raza K, Mallen CD. 2015. WHAT DOES A PRIMARY CARE ANNUAL REVIEW FOR RHEUMATOID ARTHRITIS INCLUDE? A NATIONAL GENERAL PRACTITIONER SURVEY. RHEUMATOLOGY (vol. 54, p. 66). link>
  • Hider SL, Blagojevic-Bucknall M, Case R, Clarkson K, Stack R, Raza K, Mallen CD. 2015. WHEN DO GENERAL PRACTITIONERS REFER SUSPECTED RA? A NATIONWIDE GP SURVEY. RHEUMATOLOGY (vol. 54, p. 39). link>
  • Prior JA, Roddy E, Chandratre P, Muller S, Richardson J, Hider SL, Mallen CD. 2014. ASSOCIATIONS BETWEEN GOUT CHARACTERISTICS AND ANXIETY AND DEPRESSION COMORBIDITY IN PRIMARY CARE. ANNALS OF THE RHEUMATIC DISEASES (vol. 73, p. 452). link> doi>
  • Chandratre P, Mallen C, Muller S, Richardson J, Hider S, Rome K, Roddy E. 2014. HEALTH RELATED QUALITY OF LIFE IN GOUT: CROSS-SECTIONAL ANALYSIS FROM A PROSPECTIVE COHORT STUDY. ANNALS OF THE RHEUMATIC DISEASES (vol. 73, p. 785). link> doi>
  • Helliwell T, Muller S, Hider SL, Richardson J, Mallen C. 2014. HOW DO GENERAL PRACTITIONERS IDENTIFY GIANT CELL ARTERITIS (GCA)?. ANNALS OF THE RHEUMATIC DISEASES (vol. 73, p. 1004). link> doi>
  • Ellerby N, Hider S, Mallen C, Belcher J, Roddy E. 2014. DOES INTRA-ARTICULAR CORTICOSTEROID INJECTION IN THE PRE-OPERATIVE PERIOD INCREASE THE RISK OF JOINT INFECTION FOLLOWING HIP OR KNEE ARTHROPLASTY? A SYSTEMATIC REVIEW AND META-ANALYSIS. RHEUMATOLOGY (vol. 53, p. 132). link>
  • Roddy E, Jordan KP, Chen Y, Dawes PT, Hider SL, Packham J, Stevenson K, Zwierska I, Hay EM. 2014. CONSULTATION PATTERNS FOLLOWING TREATMENT AT A MUSCULOSKELETAL CLINICAL ASSESSMENT AND TREATMENT SERVICE: A 12-MONTH PROSPECTIVE STUDY. RHEUMATOLOGY (vol. 53, p. 30). link>
  • Jenvey CA, Hider SL, Glossop JR, Packham J, Dawes P, Nixon N, Mattey D. 2014. ASSOCIATION BETWEEN LEVELS OF SERUM HEPATOCYTE GROWTH FACTOR AND JOINT REPLACEMENT OF THE HIP OR KNEE IN RHEUMATOID ARTHRITIS. RHEUMATOLOGY (vol. 53, p. 102). link>
  • Roddy E, Muller S, Rome K, Chandratre P, Hider SL, Richardson J, Mallen CD. 2014. CHRONIC FOOT PROBLEMS IN PEOPLE WITH GOUT: AN OBSERVATIONAL STUDY IN PRIMARY CARE. RHEUMATOLOGY (vol. 53, p. 163). link>
  • Richardson J, Liddle J, Hider S, Mallen C, Roddy E. 2014. DIAGNOSIS AND TREATMENT OF GOUT IN PRIMARY CARE: A QUALITATIVE STUDY OF PATIENT EXPERIENCE. RHEUMATOLOGY (vol. 53, pp. 80-81). link>
  • Chandratre P, Roddy E, Mallen C, Hider S, Liddle J, Richardson J. 2014. GOUT: NOT SOMETHING YOU BRAG ABOUT: A QUALITATIVE STUDY OF HEALTH RELATED QUALITY OF LIFE IN GOUT. RHEUMATOLOGY (vol. 53, pp. 161-162). link>
  • Vivekanantham A, Muller S, Protheroe J, Hider SL. 2014. HOW INFORMATIVE IS ON-LINE HEALTH INFORMATION: AN EVALUATION OF WEBSITES FOR POLYMYALGIA RHEUMATICA. RHEUMATOLOGY (vol. 53, p. 153). link>
  • Ellerby N, Mattey DL, Packham J, Dawes P, Hider SL. 2013. COMORBIDITY AND OBESITY ARE INDEPENDENTLY ASSOCIATED WITH FAILURE TO ACHIEVE REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS. RHEUMATOLOGY (vol. 52, p. 71). link>
  • Clarson LE, Hider SL, Belcher J, Heneghan C, Roddy E, Mallen CD. 2013. GOUT IS AN INDEPENDENT RISK FACTOR FOR ALL TYPES OF VASCULAR DISEASE: A RETROSPECTIVE COHORT STUDY IN THE UK GENERAL PRACTICE RESEARCH DATABASE. RHEUMATOLOGY (vol. 52, pp. 38-39). link>
  • Chandratre PN, Roddy E, Clarson L, Richardson J, Hider S, Mallen C. 2013. HEALTH-RELATED QUALITY OF LIFE IN GOUT: A SYSTEMATIC REVIEW. RHEUMATOLOGY (vol. 52, p. 66). link> doi>
  • Muller S, Mallen CD, Belcher J, Helliwell T, Hider SL. 2013. THE RISK OF A SUBSEQUENT CANCER DIAGNOSIS AFTER PMR: A PRIMARY CARE DATABASE STUDY. RHEUMATOLOGY (vol. 52, p. 40). link>
  • Monk HL, Muller S, Mallen C, Hider SL. 2012. ARE RHEUMATOID ARTHRITIS PATIENTS SCREENED FOR CARDIOVASCULAR DISEASE IN PRIMARY CARE?. RHEUMATOLOGY (vol. 51, pp. 37-38). link>
  • Green DJ, Muller S, Mallen C, Hider SL. 2012. FATIGUE AS A PRECURSOR TO POLYMYALGIA RHEUMATICA: A RETROSPECTIVE COHORT STUDY. RHEUMATOLOGY (vol. 51, p. 112). link>
  • Helliwell T, Hider S, Mallen C. 2011. POLYMYALGIA RHEUMATICA: DIAGNOSIS, PRESCRIBING AND MANAGEMENT IN PRIMARY CARE. RHEUMATOLOGY (vol. 50, p. 86). link>
  • Roddy E, Zwierska I, Jordan KP, Dawes P, Hider SL, Packham J, Stevenson K, Hay EM. Clinical outcome following treatment at a musculoskeletal Clinical Assessment and Treatment Service (CATS): a twelve-month prospective study. Poster presentation. 2011.
  • Helliwell T, Mallen CD, Hider SL. 2011. Polymyalgia Rheumatica: Diagnosis, Prescribing and Management in Primary Care. Rheumatology.
  • Helliwell T, Mallen CD, Hider SL. 2011. Prescribing of gastric and osteoporosis prophylaxis in the management of Polymyalgia Rheumatica in Primary Care.
  • Owen SA, Eyre S, Martin P, Hider S, Bruce IN, Barton A, Thomson W. 2010. GENETIC POLYMORPHISMS IN KEY METHOTREXATE PATHWAY GENES ASSOCIATED WITH RESPONSE TO MTX TREATMENT IN RHEUMATOID ARTHRITIS. RHEUMATOLOGY (vol. 49, p. I5). link>
  • Hider SL, Whitehurst DG, Thomas E, Foster NE. 2010. PAIN LOCATION MATTERS: THE INFLUENCE OF LEG PAIN ON SOCIETAL VALUATION OF HEALTH STATES FOR PATIENTS WITH LOW BACK PAIN. RHEUMATOLOGY (vol. 49, p. I76). link>
  • Roddy E, Zwierska I, Dawes P, Hider SL, Jordan KP, Packham J, Stevenson K, Hay E. 2010. WHO IS REFERRED TO MUSCULOSKELETAL CLINICAL ASSESSMENT AND TREATMENT SERVICES AT THE PRIMARY-SECONDARY CARE INTERFACE? THE SAMBA STUDY. RHEUMATOLOGY (vol. 49, p. I24). link>
  • Roddy E, Mallen CD, Hider SL, Jordan KP. 2009. HOW IS ACUTE GOUT MANAGED IN PRIMARY CARE?. RHEUMATOLOGY (vol. 48, pp. I101-I102). link>
  • Tanveer W, Hider SL, Brownfield A, Mattey DL, Packham JC. 2008. Depression in RA patients treated with anti-TNF is common, poorly managed and may influence anti-TNF effectiveness. RHEUMATOLOGY (vol. 47, p. II49). link>
  • Pemberton PW, Yates AP, Laing I, Hider SL, Lokko D, Ahmad Y, Bruce IN. 2007. Increased risk of atherosclerosis in women with rheumatoid arthritis: The role of adhesion molecules. ANNALS OF THE RHEUMATIC DISEASES (vol. 66, p. 148). link>
  • Hider SL, Mack LF, Shadforth MF, Thomson W, Bruce IN. 2007. Predicting outcomes of MTX therapy for RA: A combined analysis of clinical and genetic factors. ANNALS OF THE RHEUMATIC DISEASES (vol. 66, p. 329). link>
  • Hider SL, Thomson W, Bunn D, Lunt M, Symmons DP. 2007. Does shared epitope status influence response to methotrexate?. RHEUMATOLOGY (vol. 46, p. I48). link>
  • Bruce IN, Ahmad Y, Lokko D, Hider SL, Pemberton P, Yates A, Laing I. 2007. Plasma interleukin-6 (IL-6) but not CRP or ESR is closely related to clinical measures in the management of rheumatoid arthritis. Ann Rheum Dis.
  • Hider SL, Mack LF, Shadforth MF, Armstrong DJ, Bruce IN, Thomson W. 2006. Single nucleotide polymorphisms within adenosine receptor A2a are associated with gastrointestinal (GI) adverse events on MTX therapy. ARTHRITIS AND RHEUMATISM (vol. 54, p. S208). link>
  • Hider SL, Lunt M, Bunn D, Manning S, Symmons DP, Silman AJ. 2006. Can we predict the outcome of methotrexate treatment in inflammatory polyarthritis using clinical variables?. RHEUMATOLOGY (vol. 45, p. I54). link>
  • Hider SL, Mack LF, Armstrong DJ, Shadforth MF, Bruce IN, Thomson W. 2006. Single nucleotide polymorphisms within adenosine receptor A2a are associated with Gastrointestinal (GI) adverse events on MTX therapy. RHEUMATOLOGY (vol. 45, pp. I104-I105). link>
  • Hider SL, Lunt M, Bunn D, Manning S, Symmons DPM, Silman AJ. 2006. Can we predict outcome of treatment with methotrexate?. Rheumatology.
  • Hider SL, Lunt M, Manning S, Bunn D, Silman A, Symmons D. 2005. No difference in outcome between sulfasalazine or methotrexate as the first DMARD in patients with inflammatory polyarthritis. RHEUMATOLOGY (vol. 44, pp. I65-I66). link>
  • Hider SL, Lunt M, Mottram S, Bunn D, Silman AJ, Symmons DPM. 2004. Long-term outcome in inflammatory polyarthritis is not dependent on which disease-modifying drug is used first. ARTHRITIS AND RHEUMATISM (vol. 50, p. S555). link>
  • Hider SL, Hadfield J, Powley D, Brown S, Dornan T. 2004. Can Clerkship Learning Be Horizontally Integrated?. Educacion Medica 7.
  • Ahmad Y, Bodill H, Lokko D, Hider SL, Pemberton P, Yates A, Walker MG, Bruce IN. 2004. The Prevalence and Prediction of Carotid Plaque Development in Rheumatoid Arthritis Patients: A Pilot Study. Poster presentation.
  • Hider SL and Bukhari M. 2004. Variation between DAS28 score between observers: the Manchester experience. Annals of Rheumatic Diseases.
  • Hider SL, Hoggard PG, Khoo S, Back DJ, Silman AJ, Bruce IN. 2003. DMARDs as substrates for drug efflux transporters: A mechanism for drug resistance?. ANNALS OF THE RHEUMATIC DISEASES (vol. 62, p. 188). link>
  • Harrison BJ, Silam AJ, Hider SL, Herrick AL. 2002. Cigarette smoking a risk factor for digital vascular complications in systemic sclerosis. Rheumatology.
  • Hider SL, Morgan C, Bell E. 2002. Methotrexate (MTX) is not a substrate for P-glycoprotein (P-gp) in patients with Rheumatoid arthritis. Annals of Rheumatic Diseases.
  • Harrison BJ, Silman AJ, Hider SL, Herrick AL. 2001. Cigarette smoking: a risk factor for digital vascular complications in systemic sclerosis. Arthritis and Rheumatism.
  • Hider SL and Mulherin D. 2000. Early diagnosis of sacroiliitis by MRI scanning. Journal of Rheumatology.